Brian Ramnaraign
9PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 03, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.Thomas J George, Ji-Hyun Lee, David L DeRemer
|Jul 24, 2024
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.Emily J Cicali, Elizabeth Eddy, Yan Gong
|Oct 28, 2023
Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study.Kriti Gera, Doga Kahramangil, Graeme A Fenton
|Sep 27, 2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee
|Feb 22, 2023
PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials.Brian Ramnaraign, Oliver Sartor
|Nov 18, 2022
Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial.Brian H Ramnaraign, Ji-Hyun Lee, Azka Ali
Pageof 2
Frequent Collaborators
6 joint publications
Thomas J George
2 joint publications
David L DeRemer
2 joint publications
Merry Jennifer Markham
1 joint publications
Zeina A Al-Mansour
1 joint publications
Graeme A Fenton
1 joint publications
Rick Y Lin
1 joint publications
Young-Rock Hong
1 joint publications
Ibrahim Nassour
1 joint publications
Ilyas Sahin
1 joint publications
Emily J Cicali
